Advertisement
AXON vs RPRX
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXON is a Hold and RPRX is a Hold.
AXON in upward trend: price may ascend as a result of having broken its lower Bollinger Band on October 16, 2026
AXON may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 28 of 33 cases where AXON's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 85%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where AXON's RSI Indicator exited the oversold zone, 19 of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 70%.
The Moving Average Convergence Divergence (MACD) for AXON just turned positive on October 06, 2026. Looking at past instances where AXON's MACD turned positive, the stock continued to rise in 28 of 37 cases over the following month. The odds of a continued upward trend are 76%.
Following a +1.31% 3-day Advance, the price is estimated to grow further. Considering data from situations where AXON advanced for three days, in 273 of 370 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 42 of 57 cases where AXON's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 74%.
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AXON as a result. In 56 of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 74%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXON declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.
The Aroon Indicator for AXON entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating steady price growth. AXON’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 69 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AXON’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 76 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 81 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 93 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.920) is normal, around the industry mean (4.689). AXON has a moderately high P/E Ratio (126.721) as compared to the industry average of (17.589). Projected Growth (PEG Ratio) (1.949) is also within normal values, averaging (3.110). Dividend Yield (0.000) settles around the average of (0.058) among similar stocks. P/S Ratio (12.034) is also within normal values, averaging (18.367).
Aroon Indicator for RPRX shows an upward move is likely
RPRX's Aroon Indicator triggered a bullish signal on November 05, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 268 similar instances where the Aroon Indicator showed a similar pattern. In 188 of the 268 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 70%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on RPRX as a result. In 51 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 59%.
The Moving Average Convergence Divergence (MACD) for RPRX just turned positive on October 14, 2026. Looking at past instances where RPRX's MACD turned positive, the stock continued to rise in 30 of 50 cases over the following month. The odds of a continued upward trend are 60%.
RPRX moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for RPRX crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 53%.
Following a +1.76% 3-day Advance, the price is estimated to grow further. Considering data from situations where RPRX advanced for three days, in 173 of 312 cases, the price rose further within the following month. The odds of a continued upward trend are 55%.
Bearish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 16 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RPRX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 49%.
RPRX broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 15 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. RPRX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 91 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.386) is normal, around the industry mean (2.788). P/E Ratio (35.989) is within average values for comparable stocks, (-0.376). Projected Growth (PEG Ratio) (1.360) is also within normal values, averaging (9.059). Dividend Yield (0.014) settles around the average of (133.911) among similar stocks. P/S Ratio (12.870) is also within normal values, averaging (440.869).
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
AXON | RPRX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 19 | 43 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 93 Overvalued | 91 Overvalued | |
PROFIT vs RISK RATING 1..100 | 69 | 15 | |
SMR RATING 1..100 | 81 | 97 | |
PRICE GROWTH RATING 1..100 | 61 | 36 | |
P/E GROWTH RATING 1..100 | 76 | 15 | |
SEASONALITY SCORE 1..100 | 50 | 35 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
RPRX's Valuation (91) in the Pharmaceuticals Major industry is in the same range as AXON (93) in the Biotechnology industry. This means that RPRX’s stock grew similarly to AXON’s over the last 12 months.
RPRX's Profit vs Risk Rating (15) in the Pharmaceuticals Major industry is somewhat better than the same rating for AXON (69) in the Biotechnology industry. This means that RPRX’s stock grew somewhat faster than AXON’s over the last 12 months.
AXON's SMR Rating (81) in the Biotechnology industry is in the same range as RPRX (97) in the Pharmaceuticals Major industry. This means that AXON’s stock grew similarly to RPRX’s over the last 12 months.
RPRX's Price Growth Rating (36) in the Pharmaceuticals Major industry is in the same range as AXON (61) in the Biotechnology industry. This means that RPRX’s stock grew similarly to AXON’s over the last 12 months.
RPRX's P/E Growth Rating (15) in the Pharmaceuticals Major industry is somewhat better than the same rating for AXON (76) in the Biotechnology industry. This means that RPRX’s stock grew somewhat faster than AXON’s over the last 12 months.
| AXON | RPRX | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 70% | 2 days ago 48% |
| Stochastic ODDS (%) | 2 days ago 74% | 2 days ago 46% |
| Momentum ODDS (%) | 2 days ago 74% | 2 days ago 59% |
| MACD ODDS (%) | 2 days ago 76% | 2 days ago 60% |
| TrendWeek ODDS (%) | 2 days ago 69% | 2 days ago 56% |
| TrendMonth ODDS (%) | 2 days ago 71% | 2 days ago 60% |
| Advances ODDS (%) | 11 days ago 74% | 2 days ago 55% |
| Declines ODDS (%) | 4 days ago 70% | 4 days ago 49% |
| BollingerBands ODDS (%) | 2 days ago 85% | 2 days ago 60% |
| Aroon ODDS (%) | 2 days ago 79% | 2 days ago 70% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AXON’s FA Score shows that 0 FA rating(s) are green while RPRX’s FA Score has 2 green FA rating(s).
- AXON’s FA Score: 0 green, 5 red.
- RPRX’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AXON’s TA Score shows that 4 TA indicator(s) are bullish while RPRX’s TA Score has 6 bullish TA indicator(s).
- AXON’s TA Score: 4 bullish, 4 bearish.
- RPRX’s TA Score: 6 bullish, 4 bearish.
Price Growth
AXON (@Aerospace & Defense) experienced а -12.67% price change this week, while RPRX (@Biotechnology) price change was +2.49% for the same time period.
The average weekly price growth across all stocks in the @Aerospace & Defense industry was -3.16%. For the same industry, the average monthly price growth was -9.42%, and the average quarterly price growth was -20.28%.
The average weekly price growth across all stocks in the @Biotechnology industry was +7.12%. For the same industry, the average monthly price growth was -4.39%, and the average quarterly price growth was -15.58%.
Reported Earning Dates
AXON is expected to report earnings on Mar 02, 2027.
RPRX is expected to report earnings on Feb 16, 2027.
Industries' Descriptions
@Aerospace & Defense (-3.16% weekly)Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.
@Biotechnology (+7.12% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
AXON and
Correlation & Price change
A.I.dvisor indicates that over the last year, AXON has been loosely correlated with TECH. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if AXON jumps, then TECH could also see price increases.
| Ticker / NAME | Correlation To AXON | 1D Price Change % | ||
|---|---|---|---|---|
| AXON | 100% | -9.81% | ||
| TECH - AXON | 61% Loosely correlated | -0.10% | ||
| VCYT - AXON | 58% Loosely correlated | -54.30% | ||
| BEAM - AXON | 57% Loosely correlated | -6.91% | ||
| SEER - AXON | 56% Loosely correlated | -4.12% | ||
| ADPT - AXON | 56% Loosely correlated | +0.45% | ||
More | ||||
RPRX and
Correlation & Price change
A.I.dvisor indicates that over the last year, RPRX has been loosely correlated with AXON. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if RPRX jumps, then AXON could also see price increases.
| Ticker / NAME | Correlation To RPRX | 1D Price Change % | ||
|---|---|---|---|---|
| RPRX | 100% | +0.01% | ||
| AXON - RPRX | 48% Loosely correlated | -9.81% | ||
| INCY - RPRX | 47% Loosely correlated | -3.94% | ||
| VRTX - RPRX | 46% Loosely correlated | -1.19% | ||
| RIGL - RPRX | 40% Loosely correlated | -10.88% | ||
| EXEL - RPRX | 39% Loosely correlated | -5.55% | ||
More | ||||